A randomized Phase III trial of etoposide, epirubicin, and cisplatin versus 5-fluorouracil, epirubicin, and cisplatin in the treatment of patients with advanced gastric carcinoma. Turkish Oncology Group.

Date
1998
Author
Firat, D
Akbulut, H
Demirkazik, A
Ozet, A
Tas, Faruk
Ozguroglu, M
Icli, F
Celik, I
Aykan, F
Uner, A
Metadata
Show full item record
Abstract
BACKGROUND, Gastric carcinoma is a substantial health problem in Turkey, and the majority of patients present with inoperable disease. The aim of this randomized trial was to assess the activity of 5-fluorouracil versus etoposide when combined with epirubicin plus cisplatin in patients with advanced gastric carcinoma (AGC)
URI
http://hdl.handle.net/20.500.12627/138638
Collections